<DOC>
	<DOC>NCT01062009</DOC>
	<brief_summary>The purpose of the study is 1) to determine whether administration of intravenous zinc to critically ill children is safe, and 2) to determine an appropriate dose of zinc supplementation.</brief_summary>
	<brief_title>Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>Admission to pediatric intensive care unit Age between 1 month and 10 years Pediatric Risk of Mortality III score &gt; 5, OR presence of at least 1 new organ failure Anticipated pediatric intensive care unit length of stay &gt; 3 days Ability of parent or legal guardian to provide informed consent Known zinc deficiency Preexisting bone marrow failure New or existing diagnosis of diabetes mellitus Limitation of care orders in place New diagnosis of brain injury, encephalopathy Clinical contraindication for zinc supplementation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>